ES503622A0 - Un procedimiento para preparar un compuesto de cefalosporina - Google Patents

Un procedimiento para preparar un compuesto de cefalosporina

Info

Publication number
ES503622A0
ES503622A0 ES503622A ES503622A ES503622A0 ES 503622 A0 ES503622 A0 ES 503622A0 ES 503622 A ES503622 A ES 503622A ES 503622 A ES503622 A ES 503622A ES 503622 A0 ES503622 A0 ES 503622A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
cephalosporin compound
cephalosporin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES503622A
Other languages
English (en)
Other versions
ES8203908A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of ES503622A0 publication Critical patent/ES503622A0/es
Publication of ES8203908A1 publication Critical patent/ES8203908A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES503622A 1980-07-03 1981-07-02 Un procedimiento para preparar un compuesto de cefalosporina Expired ES8203908A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/165,822 US4308267A (en) 1980-07-03 1980-07-03 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido]-3-[1-(sulfaminoalkly)tetrazolthiomethyl]cephalosporins

Publications (2)

Publication Number Publication Date
ES503622A0 true ES503622A0 (es) 1982-04-01
ES8203908A1 ES8203908A1 (es) 1982-04-01

Family

ID=22600626

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503622A Expired ES8203908A1 (es) 1980-07-03 1981-07-02 Un procedimiento para preparar un compuesto de cefalosporina

Country Status (23)

Country Link
US (1) US4308267A (es)
EP (1) EP0043713B1 (es)
JP (1) JPS5745189A (es)
KR (1) KR840002046B1 (es)
AR (1) AR228606A1 (es)
AT (1) ATE9585T1 (es)
AU (1) AU547942B2 (es)
CA (1) CA1151150A (es)
DE (1) DE3166321D1 (es)
DK (1) DK286981A (es)
ES (1) ES8203908A1 (es)
FI (1) FI66876C (es)
GR (1) GR74363B (es)
HU (1) HU185934B (es)
IE (1) IE51365B1 (es)
IL (1) IL63206A (es)
NO (1) NO812268L (es)
NZ (1) NZ197573A (es)
PH (1) PH17670A (es)
PT (1) PT73292B (es)
YU (1) YU162481A (es)
ZA (1) ZA814484B (es)
ZW (1) ZW15181A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526977A (en) * 1981-10-07 1985-07-02 American Home Products Corporation 2-(3-Amino-5-isoxazolyl)-2-oxyimino-acetic acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171362A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
DE2714880A1 (de) 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
MC1259A1 (fr) 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
US4220761A (en) * 1978-09-12 1980-09-02 Fujisawa Pharmaceutical Co., Ltd. 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives

Also Published As

Publication number Publication date
AR228606A1 (es) 1983-03-30
EP0043713A1 (en) 1982-01-13
FI66876C (fi) 1984-12-10
GR74363B (es) 1984-06-28
HU185934B (en) 1985-04-28
ZA814484B (en) 1982-07-28
YU162481A (en) 1983-06-30
AU547942B2 (en) 1985-11-14
EP0043713B1 (en) 1984-09-26
KR830006310A (ko) 1983-09-20
ATE9585T1 (de) 1984-10-15
AU7234381A (en) 1982-01-07
DE3166321D1 (en) 1984-10-31
ZW15181A1 (en) 1981-09-29
IE811481L (en) 1982-01-03
CA1151150A (en) 1983-08-02
JPS5745189A (en) 1982-03-13
PT73292B (en) 1982-07-22
PT73292A (en) 1981-07-01
US4308267A (en) 1981-12-29
IL63206A (en) 1986-09-30
IE51365B1 (en) 1986-12-10
DK286981A (da) 1982-01-04
ES8203908A1 (es) 1982-04-01
KR840002046B1 (ko) 1984-11-06
FI66876B (fi) 1984-08-31
IL63206A0 (en) 1981-09-13
FI812046L (fi) 1982-01-04
PH17670A (en) 1984-11-02
NO812268L (no) 1982-01-04
NZ197573A (en) 1984-09-28

Similar Documents

Publication Publication Date Title
ES499171A0 (es) Un procedimiento para preparar antibioticos de beta-lactama
ES530715A0 (es) Un procedimiento de preparacion de un derivado de carbostirilo
ES500726A0 (es) Un procedimiento para preparar diaminopiridinas
ES489222A0 (es) Un procedimiento para preparar un compuesto de guanidinotia-zol
ES532537A0 (es) Un procedimiento para preparar un derivado de carbostirilo
ES534751A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES498922A0 (es) Un procedimiento para la preparacion de compuestos de polie-ter antibioticos
ES527790A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES500727A0 (es) Un procedimiento para preparar imidazo-piridinas
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES503134A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES505498A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES505656A0 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
ES506142A0 (es) Un procedimiento para la preparacion de nuevos acilderivadosde cefalosporina
AR228869A1 (es) Procedimiento para preparar nuevos compuestos cefalosporanicos
ES528165A0 (es) Un procedimiento para preparar derivados de cefalosporina
MX5142E (es) Procedimiento mejorado para preparar un compuesto de cefalosporina
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES542958A0 (es) Un procedimiento para preparar compuestos de cefalosporina
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES500464A0 (es) Un procedimiento para preparar 2-halogeno-acetanilidas
ES523682A0 (es) Un procedimiento para preparar compuestos de cefalosporina.
AR240938A1 (es) Un procedimiento para preparar un compuesto de imidazoquilina